China Pharma Holdings Inc. (NYSE AMERICAN: CPHI) Stock Information | RedChip

China Pharma Holdings Inc. (NYSE AMERICAN: CPHI) Listen to this Section


$0.20
+0.0200 ( +10.87% ) 263.0K

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -13,757,063.00 | $ -2,806,440.85

Date Type Amount Purchased Purchaser
2023-10-19 Sale -13757063.00 Li Zhilin

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 69 Aug 14, 2024
8-k 8K-related 14 May 30, 2024
10-q Quarterly Reports 70 May 15, 2024
8-k 8K-related 13 May 08, 2024
10-k Annual reports 98 Apr 01, 2024
8-k 8K-related 13 Mar 29, 2024
8-k 8K-related 15 Feb 23, 2024
8-k 8K-related 14 Feb 08, 2024
3 Insider transactions 1 Jan 26, 2024
8-k 8K-related 12 Dec 21, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.